HOLON, Israel (AP) — HOLON, Israel (AP) — Compugen Ltd. (CGEN) on Tuesday reported a loss of $2.1 million in its second quarter.

The Holon, Israel-based company said it had a loss of 2 cents per share.

The drug developer posted revenue of $6.7 million in the period.

The company's shares closed at $1.64. A year ago, they were trading at $1.12.

_____

This story was generated by Automated Insights (https://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CGEN at https://www.zacks.com/ap/CGEN